Promoters hold 30.8% of Parmax Pharma Limited (PARMAX). FIIs hold 0.0%, mutual funds 0.0% and other DIIs 0.0%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — |
| MF | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — |
| Other DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — |
| Retail & others | 69.2% | 69.2% | 69.2% | 69.2% | 69.2% | — | — | — | — | — | — | — |
Promoters hold 30.8% as of Jun 26; institutional ownership was broadly unchanged this quarter.
Quarterly shareholding patternas of Jun 26
